Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network.
Adolescent
Adult
Age of Onset
Aged
Amitriptyline
/ therapeutic use
Analgesics
/ therapeutic use
Anti-Inflammatory Agents, Non-Steroidal
/ therapeutic use
Female
Headache Disorders, Primary
/ drug therapy
Humans
Italy
/ epidemiology
Male
Middle Aged
Pregabalin
/ therapeutic use
Prospective Studies
Rare Diseases
Registries
Retrospective Studies
Sex Factors
Time Factors
Young Adult
Gender
Nummular headache
Primary headaches
RegistRare Network
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
19
07
2019
accepted:
26
10
2019
pubmed:
14
11
2019
medline:
1
12
2020
entrez:
14
11
2019
Statut:
ppublish
Résumé
Nummular headache (NH) is a rare headache disorder characterized by a small, circumscribed painful area of the scalp. The description of many cases in the last years has supported its re-classification as a primary headache from the International Headache Society, moving it from its previous placement in the Appendix of the International Criteria of Headache Disorders. Data were collected from a retro-prospective observational study about rare headaches promoted by the RegistRare Network, a collaborative group of seven Italian Headache Centres. According to the gender-biased profile of certain primary headaches, we have looked further NH patients from a gender perspective. Nineteen NH patients (11 men, 8 women) have been enrolled in the study. Headache onset was at 39 years and preceded approximately 8 years the diagnosis. No clinically evident differences between men and women have been found, including treatment prescriptions and headache resolution. Of note, the mean time from the onset of NH to the first visit in a Headache Centre was longer in men, compared with women (13.5 vs. 0.9 years). NH attacks were efficaciously treated with nonsteroidal anti-inflammatory drugs in 60% of patients receiving treatment. Headache prophylaxis with pregabalin and amitriptyline has been reported as effective in 40% and 67% of the treated patients, respectively. NH is a primary headache clinically heterogeneous in terms of temporal patterns and pain characteristics. Further research is needed to investigate the existence of male and female phenotypes, by clarifying whether it may be relevant for therapeutic purposes.
Sections du résumé
BACKGROUND
BACKGROUND
Nummular headache (NH) is a rare headache disorder characterized by a small, circumscribed painful area of the scalp. The description of many cases in the last years has supported its re-classification as a primary headache from the International Headache Society, moving it from its previous placement in the Appendix of the International Criteria of Headache Disorders.
METHODS
METHODS
Data were collected from a retro-prospective observational study about rare headaches promoted by the RegistRare Network, a collaborative group of seven Italian Headache Centres. According to the gender-biased profile of certain primary headaches, we have looked further NH patients from a gender perspective.
RESULTS
RESULTS
Nineteen NH patients (11 men, 8 women) have been enrolled in the study. Headache onset was at 39 years and preceded approximately 8 years the diagnosis. No clinically evident differences between men and women have been found, including treatment prescriptions and headache resolution. Of note, the mean time from the onset of NH to the first visit in a Headache Centre was longer in men, compared with women (13.5 vs. 0.9 years). NH attacks were efficaciously treated with nonsteroidal anti-inflammatory drugs in 60% of patients receiving treatment. Headache prophylaxis with pregabalin and amitriptyline has been reported as effective in 40% and 67% of the treated patients, respectively.
CONCLUSIONS
CONCLUSIONS
NH is a primary headache clinically heterogeneous in terms of temporal patterns and pain characteristics. Further research is needed to investigate the existence of male and female phenotypes, by clarifying whether it may be relevant for therapeutic purposes.
Identifiants
pubmed: 31720898
doi: 10.1007/s10072-019-04129-2
pii: 10.1007/s10072-019-04129-2
doi:
Substances chimiques
Analgesics
0
Anti-Inflammatory Agents, Non-Steroidal
0
Amitriptyline
1806D8D52K
Pregabalin
55JG375S6M
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
583-589Références
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Cephalalgia. 2012 Jun;32(8):649-53
pubmed: 22711962
Cephalalgia. 2018 Jul;38(8):1429-1441
pubmed: 29754500
Curr Pain Headache Rep. 2013 Jun;17(6):340
pubmed: 23616207
Cephalalgia. 2013 Apr;33(6):390-7
pubmed: 23378434
Neurology. 2002 Jun 11;58(11):1678-9
pubmed: 12058099
Headache. 2007 Feb;47(2):319-24
pubmed: 17300382
Headache. 2008 Mar;48(3):442-7
pubmed: 18028377
Lancet Neurol. 2017 Jan;16(1):76-87
pubmed: 27836433
Zhonghua Yi Xue Za Zhi. 2008 Nov 11;88(41):2935-7
pubmed: 19080105
Cephalalgia. 2010 Apr;30(4):507-8
pubmed: 19614682
Cephalalgia. 2007 Feb;27(2):182-6
pubmed: 17257241
Cephalalgia. 2008 Feb;28(2):186-90
pubmed: 18197886
J Neurol Sci. 2012 Sep 15;320(1-2):127-30
pubmed: 22841415
Headache. 2016 Oct;56(9):1492-1493
pubmed: 27477768
Expert Rev Neurother. 2018 Jan;18(1):9-19
pubmed: 29103335
Cephalalgia. 2009 Mar;29(3):379-83
pubmed: 19220316
J Neurol Sci. 2012 Jun 15;317(1-2):17-28
pubmed: 22482825